2177 |
Requirements for a Successful LAAC Program |
Matthew Price |
May. 09. 13 |
2176 |
Place of LAAC in the Era of New OATs |
Horst Sievert |
May. 09. 13 |
2175 |
Latest Update on LAAC and Its Clinical Evidence |
Saibal Kar |
May. 09. 13 |
2174 |
In-Stent Restenosis - Stop ISR: How to Treat DES-ISR?: Summary |
Alan C. Yeung |
May. 09. 13 |
2173 |
Beyond ISR Treatment: Viewpoint of a European DCB Consensus Group |
Franz X. Kleber |
May. 09. 13 |
2172 |
ISAR-DESIRE3: DEB, Desirable Option for DES-ISR |
Adnan Kastrati |
May. 09. 13 |
2171 |
Main Mechanism of DES ISR: Underexpension, Intimal Hyperplasia, Neoatheroscrelosis, Stent Fracture and Malapposition |
Soo-Jin Kang |
May. 09. 13 |
2170 |
PCI in Small Vessels: The Different Modalities of Currently Available Therapies |
Ramesh Singh Arjan Singh |
May. 08. 13 |
2169 |
Case Presentation: PCI in a Patient with Small Vessels |
Ning Zan Khiew |
May. 08. 13 |
2168 |
PCI in Patients with Diabetes Mellitus: Best Treatment Options to Be Considered |
Amin Ariff Nuruddin |
May. 08. 13 |